Key result
Metabolically unhealthy normal weight linked to ~220% greater cardiovascular risk in female ACS patients.
Why the study?
Obesity is a multifaceted disease with different metabolic phenotypes and sex-specific features, but its long-term cardiovascular risk across these phenotypes and by sex in ACS patients required evaluation.
Does the impact of different obesity/metabolic phenotypes on long-term cardiovascular outcomes differ by sex in patients hospitalized for acute coronary syndrome?
Cohort (n=674)
Does the impact of different obesity/metabolic phenotypes on long-term cardiovascular outcomes differ by sex in patients hospitalized for acute coronary syndrome?
Effect estimate: RR 2.2 (MUO men); RR 3.2 (MUNW women) (95% CI 1.11-1.54; 1.23-9.98)
p-value: p=0.006
In patients with acute coronary syndrome, obesity phenotypes have a sex-specific impact on long-term cardiovascular risk, with risk driven primarily by obesity in men and by metabolic unhealthiness in women.
May inform sex-specific risk stratification post-ACS; leaves open whether phenotype-targeted interventions improve outcomes.
Obesity, a major risk factor for acute coronary syndrome (ACS), is a multifaceted disease with different metabolic phenotypes and sex-specific features. Here, we evaluated the long-term cardiovascular risk by different obesity/metabolic phenotypes and by sex in ACS patients. The occurrence of the composite outcome of death, nonfatal reinfarction with or without PCI and/or stroke was evaluated in 674 patients (504 men; 170 women), consecutively hospitalized for ACS and followed-up for 7 years, who were stratified in metabolically healthy (MHNW) and unhealthy normal weight (MUNW), and in metabolically healthy (MHO) and unhealthy obese (MUO) groups. At baseline, 54.6% of patients were included in the MHNW group, 26.4% in the MUNW, 5.9% in the MHO and 13.1% in the MUO, with no sex-differences in the distribution of phenotypes. The overall rate of major outcome (100 person-years) in the reference group (MHNW) was higher in men than in women (RR: 1.19 vs. 0.6). The Kaplan–Meier curves for cumulative survival free from cardiovascular events according to obesity/metabolic status diverged significantly according to sex (log rank test, p = 0.006), this effect being more prominent in men (log 11.20; p = 0.011), than in women (log 7.98; p = 0.047). Compared to MHNW, the risk increased in obese men (RR: 2.2; 95% 1.11–1.54 in MUO group), whereas in women the risk was confined to metabolically unhealthy subjects (RR: 3.2; 95% CI 1.23–9.98, MUNW group). Our data show a sex-specific impact of obesity phenotypes on long-term cardiovascular risk in patients hospitalized for ACS.
No takes yet. Share an insight, caveat, or question.
Imbalzano et al. (2022) conducted a cohort in Acute Coronary Syndrome (n=674). Obesity/metabolic phenotypes (MUNW, MHO, MUO) vs. Metabolically healthy normal weight (MHNW) was evaluated on Composite outcome of death, nonfatal reinfarction with or without PCI and/or stroke (RR 2.2 (MUO men); RR 3.2 (MUNW women), 95% CI 1.11-1.54; 1.23-9.98, p=0.006). Obesity phenotypes showed a sex-specific impact on long-term cardiovascular risk in ACS patients, increasing risk in obese men (RR 2.2) and metabolically unhealthy normal weight women (RR 3.2).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: